HUMA
USDHumacyte Inc. Common Stock
$1.330+0.030 (2.308%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$1.300
最高
$1.340
最低
$1.220
交易量
3.25M
公司基本面
市值
249.1M
行業
生物科技
國家
United States
交易統計
平均交易量
5.40M
交易所
NMS
貨幣
USD
52週範圍
最低 $1.15當前 $1.330最高 $6.77
相關新聞
Analyst Upgrades
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.
查看更多
GlobeNewswire
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today
查看更多
Analyst Upgrades
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.
查看更多
GlobeNewswire
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –
查看更多
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。